Related Experiment Video

Updated: Apr 4, 2026

5/6 Nephrectomy Using Sharp Bipolectomy Via Midline Laparotomy in Rats
05:34

5/6 Nephrectomy Using Sharp Bipolectomy Via Midline Laparotomy in Rats

Published on: April 4, 2025

1.9K

Etiology and pediatric chronic kidney disease progression: Taiwan Pediatric Renal Collaborative Study

Yuan-Yow Chiou1, Ching-Yuang Lin2, Mei-Ju Chen3

  • 1Department of Pediatrics, Institute of Clinical Medicine, National Cheng Kung University Medical College and Hospital, Tainan, Taiwan.

Journal of the Formosan Medical Association = Taiwan Yi Zhi
|September 1, 2015
PubMed

Insights

This study identified key factors influencing chronic kidney disease (CKD) progression in Taiwanese children. Managing anemia and high blood pressure is crucial for slowing CKD advancement.

Area of Science:

  • Pediatric Nephrology
  • Chronic Kidney Disease Research
  • Public Health

Background:

  • Chronic kidney disease (CKD) affects children globally, with unique characteristics in different populations.
  • Understanding disease progression factors is vital for effective management in pediatric CKD patients.

Purpose of the Study:

  • To characterize Taiwanese children diagnosed with chronic kidney disease (CKD).
  • To identify factors contributing to the progression of CKD in this pediatric population.

Main Methods:

  • Utilized data from the Taiwan Pediatric Renal Collaborative Study, a multicenter database.
  • Employed multivariate regression analysis to pinpoint significant factors associated with CKD progression.

Main Results:

  • Included 382 children (aged 1-18 years), with CKD Stages 1-4.
  • Disease progression occurred in 14.7% of children.
  • Risk factors for progression included structural abnormalities, genetic diseases, anemia, elevated diastolic blood pressure, and high blood urea nitrogen.

Conclusions:

  • The etiology of CKD significantly influences its progression.
  • Close monitoring and treatment of anemia and hypertension can potentially slow CKD progression in children.
Abstract

Keywords:
childrenchronic kidney diseasesdisease progressionend-stage renal diseasepediatrics

More Related Videos

Use of Ultra-high Field MRI in Small Rodent Models of Polycystic Kidney Disease for In Vivo Phenotyping and Drug Monitoring07:35

Use of Ultra-high Field MRI in Small Rodent Models of Polycystic Kidney Disease for In Vivo Phenotyping and Drug Monitoring

Published on: June 23, 2015

12.1K
Isolation, Characterization, And High Throughput Extracellular Flux Analysis of Mouse Primary Renal Tubular Epithelial Cells09:40

Isolation, Characterization, And High Throughput Extracellular Flux Analysis of Mouse Primary Renal Tubular Epithelial Cells

Published on: June 20, 2018

18.8K

Related Concept Videos

Chronic Kidney Disease I: Introduction01:25

Chronic Kidney Disease I: Introduction

Chronic Kidney Disease (CKD) arises when the kidneys progressively lose their ability to function, ultimately leading to end-stage renal disease. At this advanced stage, the kidneys can no longer filter waste or maintain essential body functions, requiring renal replacement therapy (RRT) through dialysis or a kidney transplant for survival.Early-stage chronic kidney disease and detection challengesIn CKD's early stages, symptoms often remain absent because healthy nephrons compensate for...
1.2K
Chronic Kidney Disease III: Interprofessional Care01:28

Chronic Kidney Disease III: Interprofessional Care

Chronic kidney disease (CKD) requires collaborative and comprehensive management. CKD progresses through stages and can lead to end-stage kidney disease (ESKD) if untreated. Interprofessional collaboration and patient education are crucial, enabling patients to manage their health and improve their quality of life.Diagnostic approach for chronic kidney diseaseThe diagnosis of CKD primarily focuses on the glomerular filtration rate (GFR), which assesses kidney function by measuring how well...
627
Acute Kidney Injury IV: Diagnostic Studies and Prevention01:30

Acute Kidney Injury IV: Diagnostic Studies and Prevention

Accurate diagnosis and effective prevention are critical in managing Acute Kidney Injury (AKI), which is linked to high mortality rates ranging from 10% to 80%. Timely recognition of at-risk patients and careful monitoring can significantly reduce the likelihood of kidney damage.Diagnostic Assessments:The diagnostic process starts with a comprehensive medical history to identify prerenal, intrarenal, and postrenal causes.Prerenal causes, such as dehydration, hypotension, or blood loss, should...
494
Chronic Kidney Disease II: Clinical Manifestations01:24

Chronic Kidney Disease II: Clinical Manifestations

Chronic Kidney Disease (CKD) progressively impairs multiple body systems due to the accumulation of uremic toxins, which disrupt cellular functions across various organs.Neurologic symptomsNeurologic symptoms often arise early in CKD, as uremic toxin buildup drives changes in cognitive and motor functions. Patients frequently experience fatigue, headache, confusion, difficulty concentrating, and, in severe cases, seizures. Peripheral neuropathy commonly manifests as burning sensations in the...
970
Acute Kidney Injury II: Pathophysiology01:29

Acute Kidney Injury II: Pathophysiology

Acute kidney injury (AKI) causes are categorized into three primary categories based on the location of the injury: prerenal, intrarenal (or intrinsic), and postrenal causes. This classification guides clinical management and illustrates how different pathways can impair kidney function.Etiology and Pathophysiology of Acute Kidney Injury1. Prerenal causesEtiology: Prerenal Acute Kidney Injury, the most common type, occurs when reduced blood flow to the kidneys decreases filtration capacity...
1.9K
Pharmacokinetics in Pediatric Patients: Drug Excretion01:26

Pharmacokinetics in Pediatric Patients: Drug Excretion

In pediatric medicine, understanding the renal function and drug elimination nuances is crucial for administering safe and effective treatments. Newborns, in particular, display markedly slower renal functions than adults, profoundly affecting how drugs are cleared from their bodies. This slower drug clearance requires clinicians to extend the dosing intervals for many medications to prevent drug accumulation and toxicity while ensuring therapeutic efficacy.One key area where these adjustments...
377